Orange Book product · Generic (ANDA)
ASPIRIN AND DIPYRIDAMOLE
ASPIRIN; DIPYRIDAMOLE
At a glance
Aug 29, 2017
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 29, 2017
8 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
ASPIRIN; DIPYRIDAMOLE
Strength
25MG;200MG
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
TE code
AB
Application
ANDA 206753
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ASPIRIN; DIPYRIDAMOLE
- 1999AGGRENOXBrand (NDA)
NDA 020884 · BOEHRINGER INGELHEIM
- 2021ASPIRIN AND DIPYRIDAMOLEGeneric (ANDA)
ANDA 209929 · MICRO LABS
- 2019ASPIRIN AND DIPYRIDAMOLEGeneric (ANDA)
ANDA 210318 · GLENMARK SPECLT
- 2019ASPIRIN AND DIPYRIDAMOLEGeneric (ANDA)
ANDA 204552 · CHARTWELL MOLECULAR
- 2018ASPIRIN AND DIPYRIDAMOLEGeneric (ANDA)
ANDA 209048 · DR REDDYS
- 2018ASPIRIN AND DIPYRIDAMOLEGeneric (ANDA)
ANDA 208572 · SUN PHARM
- 2017ASPIRIN AND DIPYRIDAMOLEGeneric (ANDA)
ANDA 206964 · ANI PHARMS
- 2017ASPIRIN AND DIPYRIDAMOLEGeneric (ANDA)
ANDA 207944 · PH HEALTH
- 2017ASPIRIN AND DIPYRIDAMOLEGeneric (ANDA)
ANDA 206739 · SANDOZ
- 2016ASPIRIN AND DIPYRIDAMOLEGeneric (ANDA)
ANDA 206392 · AMNEAL PHARMS
- 2009ASPIRIN AND DIPYRIDAMOLEGeneric (ANDA)
ANDA 078804 · BARR
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
